Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, August 21, 2025
Piramal Pharma Solutions and NewAmsterdam Pharma Company announced the opening of a dedicated oral solid dosage (OSD) form suite at Piramal's facility in Sellersville, Pennsylvania, USA. As one of Piramal Pharma Solutions' focused drug product ...
read more
Thursday, October 30, 2025
Piramal Pharma announced its strategic partnership with Korean biotech firm IntoCell to expand its offerings in the rapidly growing antibody-drug conjugate (ADC) and bioconjugate market.
read more
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services announced a strategic collaboration under which Piramal will refer applicable customers seeking ADC manufacturing technology to Aji Bio-Pharma and AJICAP™. Aji Bio-Pharma will refer Piramal ...
read more
Piramal Pharma Solutions announced the installation of a Korsch X3 high containment tablet press at its integrated API and oral solid development and manufacturing site in Morpeth, UK.
read more
Tuesday, September 16, 2025
Piramal Pharma Solutions announced its acquisition of a Korsch XM-12 bilayer tablet press at its drug product facility in Morpeth, UK.
read more
Tuesday, December 02, 2025
Piramal Pharma Solutions announced the successful completion of its journey to compliance with global requirements for nitrosamine impurities in pharmaceuticals.
read more
Thursday, August 28, 2025
Piramal Pharma Limited (PPL) published its fourth annual Sustainability Report for FY2025, documenting performance and progress under the theme “Innovating Responsibly. Growing Sustainably.”
read more
Thursday, January 29, 2026
Piramal Pharma Limited reported consolidated revenue from operations of ?2,140 crore for Q3 FY26, down 3% from ?2,204 crore in Q3 FY25, with 9M FY26 revenue declining 4% to ?6,117 crore from ?6,397 crore.
read more
Piramal Pharma Limited’s Pharma Solutions business, held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company’s site in Aurora, Ontario.
read more
The acquisition will add peptide API development and manufacturing capabilities.
read more
Piramal Pharma Ltd (PPL) announced the addition of three members to its board of directors. The company has added Mr. Peter Stevenson, Ms. Nathalie Leitch and Mr. Sridhar Gorthi to the board.
read more
Thursday, February 01, 2024
Revenue from Operations grew by 14% YoY both in Q3FY24 and 9MFY24, driven by double digit growth across all the three businesses
read more
Thursday, November 06, 2025
Piramal Pharma announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2025.
read more
Tuesday, October 07, 2025
Piramal Pharma Solutions has introduced the PODs (Plan, Own, and Deliver) Project Execution System at its Aurora, Canada facility. The Aurora site implemented this innovative system to execute seamless deliveries to customers amidst a growing ...
read more
Piramal Pharma Limited has announced a $90M investment plan towards expanding two of the Company’s US facilities. These expansions are in response to ongoing demand from US customers, in support of the trend towards US onshoring of drug supply, and ...
read more